Adaptam Therapeutics is a series a startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
Adaptam Therapeutics is a biotechnology company focused on developing novel immunotherapies for cancer. They are pioneering a platform to discover and develop personalized T-cell receptor (TCR)-based therapeutics.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky